Van Cutsem, E., Martinelli, E., Cascinu, S., Sobrero, A., Banzi, M., Seitz, J., . . . Zaniboni, A. (2019). Regorafenib for patients with metastatic colorectal cancer who progressed after standard therapy: Results of the large, single‐arm, open‐label phase IIIb CONSIGN study. The oncologist, 24(2), . https://doi.org/10.1634/theoncologist.2018-0072
Chicago-Zitierstil (17. Ausg.)Van Cutsem, Eric, et al. "Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐arm, Open‐label Phase IIIb CONSIGN Study." The Oncologist 24, no. 2 (2019). https://doi.org/10.1634/theoncologist.2018-0072.
MLA-Zitierstil (9. Ausg.)Van Cutsem, Eric, et al. "Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐arm, Open‐label Phase IIIb CONSIGN Study." The Oncologist, vol. 24, no. 2, 2019, https://doi.org/10.1634/theoncologist.2018-0072.